Cargando…

Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function

Obesity is one of the leading preventable causes of cancer; however, little is known about the effects of obesity on anti-tumor immunity. Here, we investigated the effects of obesity on CD8 T cells in mouse models and patients with endometrial cancer. Our findings revealed that CD8 T cell infiltrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyck, Lydia, Prendeville, Hannah, Raverdeau, Mathilde, Wilk, Mieszko M., Loftus, Roisin M., Douglas, Aaron, McCormack, Janet, Moran, Bruce, Wilkinson, Michael, Mills, Evanna L., Doughty, Michael, Fabre, Aurelie, Heneghan, Helen, LeRoux, Carel, Hogan, Andrew, Chouchani, Edward T., O’Shea, Donal, Brennan, Donal, Lynch, Lydia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932531/
https://www.ncbi.nlm.nih.gov/pubmed/35103755
http://dx.doi.org/10.1084/jem.20210042
Descripción
Sumario:Obesity is one of the leading preventable causes of cancer; however, little is known about the effects of obesity on anti-tumor immunity. Here, we investigated the effects of obesity on CD8 T cells in mouse models and patients with endometrial cancer. Our findings revealed that CD8 T cell infiltration is suppressed in obesity, which was associated with a decrease in chemokine production. Tumor-resident CD8 T cells were also functionally suppressed in obese mice, which was associated with a suppression of amino acid metabolism. Similarly, we found that a high BMI negatively correlated with CD8 infiltration in human endometrial cancer and that weight loss was associated with a complete pathological response in six of nine patients. Moreover, immunotherapy using anti–PD-1 led to tumor rejection in lean and obese mice and partially restored CD8 metabolism and anti-tumor immunity. These findings highlight the suppressive effects of obesity on CD8 T cell anti-tumor immunity, which can partially be reversed by weight loss and/or immunotherapy.